Abstract:Background: Circular RNAs (circRNAs), a novel type of ncRNAs, are covalently linked to make up circular configuration via a loop structure. Accumulating evidence indicate that circRNAs are potential biomarkers and key regulators in the development and progression of tumors. However, the precise role of circRNAs in renal cell carcinoma (RCC) remains unknown.Methods: Though circRNA high-throughput sequencing from RCC cell lines, we determined circRNA TLK1 (circTLK1 ) as a novel candidate circRNA derived from TLK1 gene. Quantitative real-time PCR (qRT-PCR) was performed to detect the expression levels of mRNAs, circRNAs and miRNAs in RCC tissues and cells. Loss-of function experiments were executed to detect the biological roles of circTLK1 on the phenotypes of RCC cells in vitro and in vivo. RNA-FISH, RNA-pull down, dual-luciferase reporter, western blot and immunohistochemistry assay were used to investigate the molecular mechanisms underlying the functions of circTLK1.Findings: CircTLK1 is overexpressed in RCC and positively corelated with distant metastasis and unfavorable prognosis. Silence of circTLK1 significantly inhibits the proliferation, migration and invasion of RCC cells in vitro and in vivo. Mechanistically, circTLK1 is mainly distributed in the cytoplasm and positively regulates CBX4 expression by sponging miR-136-5p. In addition, forced expression of CBX4 reverses the phenotypes inhibition of RCC cells induced by circTLK1 suppression. Moreover, CBX4 expression is positively corelated with VEGF expression in renal cancer tissues. Knockdown of CBX4 significantly inhibited VEGF expression in RCC cells.Interpretation: Collectively, our findings demonstrate that circTLK1 plays a critical role in RCC progression by sponging miR-136-5p to increase CBX4 expression. CircTLK1 may act as a diagnostic biomarker and therapeutic target for RCC.Funding Statement: This study was supported by grants from Guangdong Key Laboratories (2017B030314074) and the Shenzhen Project of Science and Technology (JCYJ20170413100245260).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: This study was approved by the ethical committee of Perking University Shenzhen Hospital. All patients agreed that their samples could be applied to the experimental studies and paper presentations.In vivo assay was approved by the animal management committee of Perking University Shenzhen Hospital, and all experimental procedures and animal care were in line with the institutional ethics guidelines for animal experiments.

Circptpn12 Promotes the Progression and Sunitinib Resistance of Renal Cancer Via Hnrnpm/il-6/Stat3 Pathway.

Circular RNA Circagap1 Promotes Sunitinib Sensitivity in Renal Cell Carcinoma Via Sponging Multiple PDGFR-targeted Mirnas

Circular RNA Circsnx6 Promotes Sunitinib Resistance in Renal Cell Carcinoma Through the Mir-1184/Gpcpd1/ Lysophosphatidic Acid Axis.

Molecular Mechanism of Circrnas in Drug Resistance in Renal Cell Carcinoma

CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification

circFOXO3 Induced by KLF16 Modulates Clear Cell Renal Cell Carcinoma Growth and Natural Killer Cell Cytotoxic Activity through Sponging miR-29a-3p and miR-122-5p

KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis

LINC00160 Mediates Sunitinib Resistance Via SAA1/STAT3 Signaling Pathways and ABCB1 Transmembrane Transport in Renal Cell Carcinoma

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma

CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1

Circ-IP6K2 suppresses tumor progression by modulating the miR-1292-5p/CAMK2N1 signal in clear cell renal cell carcinoma

Circ_0011292 knockdown mitigates progression and drug resistance in PTX ‐resistant non‐small‐cell lung cancer cells by regulating miR ‐433‐3p/ CHEK1 axis

Circptn Promotes the Progression of Non-Small Cell Lung Cancer Through Upregulation of E2F2 by Sponging Mir-432-5p

Circprrc2a Promotes Angiogenesis and Metastasis Through Epithelial-Mesenchymal Transition and Upregulates TRPM3 in Renal Cell Carcinoma.

P21-Activated Kinase 1 Determines Stem-Like Phenotype and Sunitinib Resistance Via NF-κB/IL-6 Activation in Renal Cell Carcinoma

Upregulated <i>circPDK1</i> Promotes RCC Cell Migration and Invasion by Regulating the <i>miR</i>-<i>377</i>-<i>3P</i>-<i>NOTCH1</i> Axis in Renal Cell Carcinoma

CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis

Tumor Cell-Derived Exosomal Circ-Prkci Promotes Proliferation of Renal Cell Carcinoma Via Regulating Mir-545-3p/ccnd1 Axis.

The Mechanism Of Action And Resistance Of Sunitinib In Rcc.

Progress in Mechanisms and Treatment of Sunitinib Resistance in Renal Cell Carcinoma

CircTLK1 Promotes the Proliferation and Metastasis of Renal Cell Carcinoma Through Sponging Mir-136-5p and Regulating CBX4 Expression